Figure 1. In situ hybridization analysis of angptl4 mRNA expression in renal tumors.
H&E (A) and dark-field (B) views of angptl4 mRNA expression in ccRCC (×4). Bright-field (C) and dark-field (D) views of lymph node metastasis of ccRCC (×10). Bright-field (E) and dark-field (F) views of angptl4 mRNA expression in multilocular cystic RCC (×10). Bright-field (G) and dark-field (H) views of angptl4 mRNA expression in ccpRCC (×10). Bright-field (I) and dark-field (J) views of angptl4 mRNA expression in type 2 pRCC (×10). Bright-field (K) and dark-field (L) views of angptl4 mRNA expression in chRCC (×10). Note: Strong expression of angptl4 mRNA in primary (A, B) and secondary ccRCC (C, D), in multilocular cystic RCC (E, F), and in ccpRCC (G, H). Absence of angptl4 mRNA expression in type 2 pRCC (I, J), and chRCC (K, L).
